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Fibrous technologies (such as membranes, films, patches and filters) and their enabling 
engineering platforms have gained considerable interest over the last decade. In this 
study, novel fibrous constructs from a unique engineering platform were developed 
based on hybrid electrohydrodynamic (EHD) technology; incorporating functional and 
bioactive materials within random and aligned fibrous formulation geometries. 
Complex constructs were engineered using 3D printing (polycaprolactone, PCL, for 
sustained delivery) and electrospinning (polyvinylpyrolidone, PVP, for rapid release) 
in an intercalating material layer-by-layer format using a side-by-side technological 
approach. Here, structure generation proceeded with deposition of ordered PCL fibers 
enabling well-defined void size and overall dimension, after which randomly spun PVP 
fibers formed a construct overcoat (as a membrane). Differences between polymer 
dissolution rate, hydrophilicity, mechanical properties and functional material hosting 
(and linked external auxiliary magnetic field trigger) provided opportunities to 
modulate antibiotic drug (tetracycline hydrochloride, TE-HCL) release. In vitro cell 
studies using human umbilical vein blood vessel cell line demonstrated device 
biocompatibility and Escherichia Coli (E. coli) was selected to demonstrate anti-
bacterial function. Overall, a new hybrid engineering platform to prepare customizable 
and exciting multi-faceted drug release constructs is elucidated. 
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Strategies and methods to modulate drug release behaviour have evolved significantly 
over the last few decades; from polymeric system to nano-functionalized pharmaceutics 
[1, 2]. Specifically, a variety of systems have been developed to meet the needs of 
selected active release behaviour (i.e. immediate, pulsatile, delayed, sustained and 
biphasic releases [3-5]). Amongst these, sustained drug release systems are currently 
the most explored; with recent efforts focusing on enhancing drug concentration in 
blood (within therapeutic window) or target tissues therefore displaying prolonged 
activity [6, 7]. While this provides a sustained active release period, rapid release 
features are often neglected, which becomes problematic if an active needs to be 
delivered immediately, providing a quick biological response. 
Electrospinning (ES) has great potential in generating fibrous materials for drug 
delivery applications [8]. Using such filamentous structure, a host of drugs such as 
antibiotics and anticancer agents can be delivered [9]. Electrohydrodynamic (EHD) 
continuous jetting is based on digitally-controlled deposition of materials (often layer 
by layer) to create well-ordered freeform geometries, unlike random structures obtained 
when using ES [10]. EHD continuous jetting methods currently deployed in the 
engineering of pharmaceuticals permit simple, accurate, cheap, structured and tailored 
developments of drug delivery dosage forms. 
Polyvinylpyrrolidone (PVP) is a synthetic, biocompatible and non-toxic polymer which 
has been widely used as a pharmaceutical excipient (for dosage form development) [11, 
12]. Polycaprolactone (PCL) is a hydrophobic polymer with desirable 
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physicochemical properties, which has been used in diffusion-controlled delivery 
systems [13].  
Fe3O4 nanoparticles (NPs) are rapidly emerging as opportunistic healthcare materials 
[14]. Recent explorations have shown their potential in cell separation, diagnostics and 
advanced therapy regimes [15]. In addition, co-encapsulation of Fe3O4 NPs with an 
active embedded into a polymeric matrix system affords trigger based drug release 
mechanisms (using an external auxiliary magnetic field (AMF)). In this instance, the 
functionality of the external trigger is dependent on NP loading within the formulation, 
strength of the applied field and geometrical features of the drug delivery system [16]. 
This approach is valuable since it has shown to improve pharmacokinetics of retarded 
active release systems as and when needed [17].  
In recent times multi-step or two tiered drug release systems have gained popularity 
and these have focused on external triggers, materials and engineering of new and 
complex structures [18, 19]. However, methods to design and develop such drug 
delivery systems (combining both rapid and sustained mechanisms) remain limited. To 
accommodate this several approaches have been undertaken including controlled 
layering or core -shell structures [20]. Conventional methods (e.g. wet granulation) 
have also been used to encapsulate or host multiple actives.  
In this study, EHD continuous jetting and ES techniques are arranged in a side-by-side 
hybrid-engineering platform to fabricate mechanically and biologically improved 
constructs for drug delivery applications through a layer-by-layer materials approach. 
A non-core shelled delivery system is engineered. In addition to space, process stages 
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and time benefits the developed system enables greater loading capacity, simultaneous 
entrapment of therapies where formulations are non-compatible, ease of operation [9] 
and the ability to alter specific components as required (specific drug and tailored drug 
loading capability) Multi-layered and well-aligned PCL fibers were used as the 
construct base (mechanically enforcing) and electrospun PVP membranes provided an 
overcoat layer. The well-established difference in dissolution and degradation rate 
between these polymers provided a two-tier active (TE-HCL) release mechanism. TE-
HCL, which belongs to a group of broad-spectrum antibiotics and is commonly used to 
treat and control bacterial skin infections, was used as the model active compound [21-
24].  
2. Materials and methods 
2.1 Materials 
Polyvinyl pyrrolidone (PVP, Mw = 1.3×10
6 g/mol) and Poly ɛ-caprolactone (PCL, mean 
Mw=8 × 10
4 g/mol) were purchased from Sigma-Aldrich, St Louis, USA. Tetracycline 
hydrochloride (TE-HCL) was purchased from Amersco, USA. Fe3O4 NPs (mean 
particle diameter~ 20nm) were purchased from HWRK Chem, China. Glacial acetic 
acid, absolute ethyl alcohol and phosphate buffer saline (PBS, pH 7.4) were supplied 
by Sinopharm Chemical Reagent, China. All chemicals and reagents were analytical 
grade.  
 
2.2 Solution and suspension preparation 
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For EHD continuous jetting, PCL polymer solution (20% w/w) was prepared using 
acetic acid. To ensure complete dissolution, initial mixtures were mechanically stirred 
for 5 hrs at the ambient temperature (24 ℃). Fe3O4 NPs were incorporated into selected 
PCL solutions and a second suspension was prepared which hosted both Fe3O4 NPs (0.5 
% w/w, of the final composition) and the model active TE-HCL (0.5% w/w, of the final 
composition). The drug suspension was stirred for 6 hrs to ensure complete dissolution. 
Both mixtures were placed in mild bath sonication (2 hrs), prior to EHD engineering, 
which resulted in near homogenous suspensions. TE-HCL release from constructs were 
evaluated with and without external stimuli (AMF). 
A PVP/TE-HCL solution was prepared by adding both drug and polymer to ethyl 
alcohol at 15 and 0.5% w/w, respectively, (of the overall formulation) followed by 
mechanical stirring (1 hr). Upon complete dissolution, a known qunaity of the solution 
was magnetized through addition of Fe3O4 NPs (0.5% w/w of the final composition). 
The mixture was dispersed for 2 hrs by mild bath sonication to ensure a homogenous 
system.  
 
2.3 Complex construct engineering  
A schematic diagram showing the hybrid EHD system (EHD continuous jetting and 
ES) is shown in Fig. 1. The hybrid system, providing a patterned PCL fiber platform 
with randomly orientated PVP fibrous mesh overcoat, comprised an X-Y-Z motion 
stage controlled using mechatronics. This enabled precise programmable movement 
during construct engineering. Two high-voltage power supplies capable of generating 
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~30 KV (Glassman high voltage Inc. series FC, USA) were indiviudally connected to 
EHD continuous jetting and ES nozzles, both of which possessed an inner diameter of 
0.5 mm. PCL and PVP/TE-HCL formulations were loaded separately into 5 ml syringes 
and were subsequently mounted into the precision syringe pumps (KD Scientific 
KDS100, USA). A conductive glass collector was mounted onto the programmable X-
Y-Z motion stage as the ground electrode. The applied voltage for EHD continuous 
jetting was set in the range 2.0~2.2 kV, and the applied voltage for ES was maintained 
at 9.0 kV. The deposition distance were set at 5 mm and 6 cm, for EHD continuous 
jetting and ES, respectively. To maintain a stable cone-jet for the process, solution feed 
rate for EHD continuous jetting and ES were selected as 0.2 and 0.8ml/h, respectively.  
Fabrcation proceeded by patterning of a 3D PCL based scaffold (first) with precise 
designated filametnous layers (20 layer overprints). The next step involved the 
deposition of a PVP membrane comprising randomly oritnetated fibers via ES for 2 
mins. All experiments were performed at the ambient temperature (25℃) and relative 
humidity (40~ 60%). 
 
2.4 Material characterization  
Construct surface morphology was characterized using optical (Phenix 
BMC503-ICCF, China) and scanning electron microscopy (SEM, FEI Quanta 
650, Netherland). For SEM analysis, samples were applied with a thin layer of 
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platinum for 60 s using a sputter coater (108auto, Cressington Scientific 
Instruments Ltd., UK) at a current intensity of 25 mA to prevent sample charging.  
All data was exported for analysis and graphs were plotted using Origin software 
(OriginLab, USA). Fiber diameters were quantified using a statistical distribution 
that involved 50 fibers (50 layer overprints) for each experimental condition. 
Error bars were plotted to represent the mean ± standard deviation. 
Construct hydrophobicity was assessed using an optical contact angle & interface 
tension meter (SL2000KB, Kino Industry Co., Ltd, USA). The contact angle of 1μL 
PBS droplet on selected construct surfaces was measured at pre-determined time 
intervals. Fourier Transform Infra-Red (FTIR) was used to determine construct 
composition, interactions and material stability. Samples were prepared using the KBr 
pellet pressing method. For this, 2 mg of each construct sample was dispersed in 200 
mg of KBr medium by grinding and then compressed into transparent pellets (pressure-
12 MPa). Pellets were then scanned with FTIR (Ir Affinity 1, Shimadzu, Japan) and 
aquired spectrum possessed a resolution of 4 cm-1 (4000-450cm-1). Each spectrum was 
obtained using 20 scans. 
In order to investigate pattern impact on construct mechanical properties; tensile tests 
were performed using a universal materials tester (Zwick/Roell Z020, Zwick, 
Germany). The selected gauge length was 15 mm, and samples were extended along 
the fiber axis with a 500 N load cell at a crosshead speed of 10 mm/min at the ambient 
temperature (24 ℃). Construct samples (7 × 2.5 cm) were prepared for tensile tests. For 
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each sample set, measurements were taken in triplicate after which the mean tensile 
strength was calculated. 
 
2.5 In vitro drug release study 
Drug release was monitored according to a method deployed in a previous study [15]. 
Assays comprised 10 ml release medium (PBS, pH=7.4) with 30 mg of test sample. 
Due to the presence of Fe3O4 NPs in some constructs, AMF application impact on drug 
release from particle hosting constructs was explored. For non-AMF stimulated 
samples, 2 ml supernatant was removed for UV measurement and replaced with an 
equal volume of fresh release medium at pre-determined time intervals. Concentration 
of TE-HCL in supernatant was measured using UV absorption at a wavelength of ~364 
nm (UV-2600 spectrophotometer, Shimadzu, Japan). 
For AMF related studies, a field was generated around selected vials hosting samples 
and near identical experiments were conducted without AMF application, serving as 
the control group. A sinusoidal alternating electric current was generated via functional 
signal generation (AFG1022, Tektronix, USA) and circulated into a copper solenoid 
after being magnified through a power amplifier (HFVA-42, Foneng Science and 
Technology Co.,Ltd., Nanjing, China). The AMF was delivered at a fixed operating 
frequency of 40 kHz and the output current was maintained at 0.4A (induced magnetic 




The proposed drug release mechanism from constructs (based on the intrinsic nature of 
PVP and PCL) was assumed to be diffusive in nature [16]. In order to validate this 
assertion, in vitro drug release data (from constructs without AMF application) were 
fitted to Korsmeyer-Peppas and Higuchi models. For this constructs F1-F4 were 
selcted. The Korsmeyer-Peppas model is normally applied to analyze drug release when 
the mechanism is not clear. In contrast, the Higuchi model is conventionally used to 
confirm diffusive drug release from a polymer matrix system . The Korsmeyer-Peppas 
model is expressed as shown in Eq. (1): 
𝑴𝒕
𝑴∞
= 𝒌𝒕𝒏                    (1) 
Here, Mt is the accumulative quantity of drug released at time t, and M∞ represents the 
initial drug loading (Mt/M∞ represents the fraction drug released at time t), k is a 
constant characteristic and n is the release exponent which indicates the release 
mechanism [25]. The Higuchi model is presented as shown in Eq. (2):  
𝑴𝒕 = 𝒌𝑯𝒕
𝟏
𝟐                  (2) 
Here, Mt is the quantity of cumulative drug release after time t and kH is the Higuchi 
constant [26]. 
 
2.6 Antimicrobial activity, cell culture and morphology 
Construct antimicrobial activity was investigated using E. coli as the test 
microorganism over a 24 h incubation period. Selected construct samples (as discs 
ca.10 mm) were assessed. Construct biocompatibility was investigated through cell 
proliferation and morphology. Human umbilical vein endothelial cells (HUVEC) were 
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selected, and were provided by American Type Culture Collection (ATCC). Firstly, 
HUVEC were cultured in Dulbecco’s modified eagle's medium with 1% antibiotic and 
antimycotic solutions (DMEM, high glucose; Gibco, USA), supplied with 10% fetal 
bovine serum (FBS, Gibco, USA) in 6 cm diameter cell culture dishes at 37℃ in 
humidified atmosphere of 5% CO2. The culture medium was changed every 2 days. The 
samples were fixed with stainless steel rings in the culture dishes [27]. The samples 
were disinfected by soaking in ethanol for 1 h followed by washing with PBS (three 
times). Samples were then soaked overnight in cell culture medium before seeding with 
cells. 
HUVEC were seeded on two types of construct samples at a density of 1.0×105 
cells/cm2. After 1 and 4 days cell culture, cell morphology was determined following a 
previously reported method [27]. Fluorescent imaging was used to visualize cell growth 
and morphology on construct samples. Briefly, HUVEC cultured on samples were fixed 
using 4% (v/v) formalin (20 min), and were then washed three times using PBS. Cells 
were then permeabilized using 0.1% Triton X-100 in PBS for 5 min. After washing 
with PBS, cell cytoskeleton and nuclei were stained with Alexar Fluor 546 phalloidin 
(Yeasen Biology Technology Co., LTD, China) (1:100 dilution) and 4’,6’-diamidino-
2-phenylindole hydrochloride (DAPI, Yeasen Biology Technology Co., LTD, China) 
for 20 min and 5 min, respectively. Samples were then washed three times (PBS) after 
each staining. Subsequently, cells were visualized using an inverted fluorescent 
microscope (Nikon, Eclipse Ti-S, Japan). 
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3. Results and discussion 
3.1 Fabrication of complex constructs 
Fig. 1 shows a schematic diagram of the EHD-hybrid engineering platform utilized in 
this study. In order to facilitate side-by-side co-engineering function the ES and EHD 
continuous jetting were setup adjacently on to a programmable X-Y-Z motion stage, 
providing controlled movmement in three dimensions. Four types of polymeric 
components (F1, F2, F3, and F4) were desgined and engineered, through ES, EHD 
continuous jetting or a combination. Where EHD continuous jetting was used, the 
projected deposition pathway was uploaded onto the program controller. A detailed 
description of these structures is provided in Table 1(a). 
Fig. 2 shows optical and electron micrographs of random electrospun fibers and aligned 
3D printed fibers generated using hybrid technology. Fig. 2(a) shows random fibrous 
PVP membranes incorporating antibiotic TE-HCL and Fe3O4 NPs (F1), while Fig. 2(b) 
presents patterned 3D PCL grids also hosting identical active and functional materials 
(comprised of horizontal and vertical filaments; stacked ten times to form a square 
pattern possessing uniform void spacing of 500 μm, F2). A complex construct 
comprising PCL printed structures and fibrous PVP membrane (F3) is shown in Fig. 
2(c), while multiple intercalation with aligned–random-aligned configuration is shown 
(F4) in Fig. 2(d). Electron micrographs show random PVP and patterned PCL fibers 
possess smooth and near uniform diameters (respective of their individual forming 
method) when prepared using the hybrid platform (Fig. 2(a1)-2(d1)). The inset in Fig. 
2(d1) shows formulation F4 at high magnification, in which PVP fibers are clearly 
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observable. Fig. 2(d) indicates the hybrid engineering platform developed in this study 
could be used to fabricate constructs with various geometries. Aligned 3D PCL 
foundation component fibers were near uniform with a mean diameter of 25 μm. 
Randomly orientated PVP fibers show a reduced mean diameter (~1 μm) when 
compared to printed architectures. This difference is attributed to enhanced drying time 
arising from the increased deposition distance along with ES instabilities; which 
expedite solvent evaporation and fiber shrinkage during forming. 
In order to further demonstrate structure generation and geometrical complexity and 
arising from EHD-hybrid engineering, five construct types (P1-P5) were fabricated 
using the integrative apparatus (detailed descriptions are shown in Table 1(b)). All 
constructs comprised two components; a 3D patterned structure enforcing platform and 
a superficial non-ordered topping membrane. The first geometry (P1) possesses PCL 
fibers arranged in well intercalated horizontal and vertical stacks; with alternating 
layers for 10 repetitions (void size ~ 500 μm). The overall construct is then completed 
with a fibrous PVP membrane loaded with TE-HCL antibiotic. The second geometry 
(P2) comprises PCL filaments stacked in the X axis for ten repetitions followed by a 
further ten stacks in the Y axis. For P2 the void size was maintained at ~ 500 µm and 
an identical PVP fibrous membrane was fabricated to blanket the printed architecture. 
Geometry P3 comprised horizontal and angled filaments with alternating layering for 
ten repetitions giving rise to parallelogram grid voids (interior angle 45°, length ~ 500 
μm). As deployed previously, TE-HCL loaded fibrous PVP membranes were used to 
complete construct engineering. The penultimate geometry, P4, was identical to P1, 
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however, in this instance 3D patterned PCL filaments were prepared to host Fe3O4 NPs. 
The last geometry (P5) was an extension to P4; with PVP membranes also 
encapsulating Fe3O4 NPs (in addition to TE-HCL). 
Fig. 3(a)-(e) show optical micrograph plan views of constructs P1 to P5. Both patterned 
foundation and random superficial layers are observed. Fig. 3(a1)-(e2) show electron 
micrographs of constructs P1-P5 observed from plan and inclined views. In accordance 
with the optical data, electron micrographs present similar PCL grid patterned 
foundations blanketed with a fibrous PVP membrane. Interestingly, a brighter contrast 
intensity is apparent for 3D PCL ‘square’ foundation grids. This is attributed to PCL 
stack fiber height that becomes compromised for angular patterns, leading to a 
difference in contrast, as shown in Fig. 3(a1)-3(e1). 
Fig. 3(a2)-3(e2) show filamentous 3D PCL patterns with near uniform diameters and 
smooth surface morphology. For P1, P4 and P5 constructs; alternating horizontal and 
vertical fiber deposition was achieved at an angle of 90° (Fig. 3(a2), (d2) and (e2), 
respectively). For construct P2, the PCL foundation platform comprised ten stacked 
horizontal filaments followed by ten stacked vertical structures with excellent accuracy 
and precision as shown in Fig. 3(b2) with a neat parallelogram void shown further for 
P4 in Fig. 3(c2). 
 
3.2 Fourier transform infra-red spectroscopy 
Fourier Transform Infrared Spectroscopy (FTIR) was used to determine chemical 
composition of constructs using the 4000-450 cm-1 region. FTIR spectra of pure 
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materials and engineered constructs reveal sample composition, as shown in Fig. 4(a) 
& (b). The presence of PVP polymer was confirmed by absorbance at 1018 and 1290 
cm-1, which are assigned to C-N stretching. Characteristic absorption bands at 2358 and 
2954 cm-1 belong to stretching vibrations of C-H. Another characteristic peak attributed 
to stretching vibrations is found at 1496 cm-1 and is attributed to C=O [12]. PCL 
polymer produces a strong carbonyl (C=O) peak at 1729 cm-1 and other absorptions 
between 2868 and 2949 cm-1 arising from methylene (CH2) groups [15], Similar bands 
are observed in spectra for constructs P1-P5 shown in Fig. 4(b). A characteristic band 
of Fe3O4 is observed at 580 cm
-1 and is attributed to the Fe-O bond [17], which can be 
observed in both constructs P4 and P5 as shown in Fig. 4(b). Characteristic absorption 
peaks for TE-HCL are observed at 1246 cm-1 (C-N), 1288 cm-1 (C-H stretching 
vibration) and 1460 cm-1 (O-H stretching vibration) for all spectra of constructs hosting 
the antibiotic [12], as shown in Fig. 4(b). FTIR spectroscopy indicated PVP, PCL and 
Fe3O4 NPs construct components remain stable during EHD. 
 
3.3 Mechanical Properties 
Numerous studies have shown mechanical property enhancement of electrospun 
membranes upon inclusion of metallic nanoparticles [28, 29]. In this study, construct 
mechanical properties were also improved through addition of nanoparticles. 
Furthermore, base PCL patterned geometry and design also provided a route to enhance 
such features.   
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Mechanical properties of constructs F1-F4 were investigated as shown in Fig. 4(c). 
Randomly orientated PVP fibers (F1) displayed poor tensile stress (< 0.2 MPa), which 
is in agreement with a previous report[30]. Aligned PCL foundations for construct F2 
displayed a maximum tensile stress of >0.4 MPa. However, the tensile stress of F3 
(angular patterning) was lower than F2, but exhibited an increase in tensile strain. 
Moreover, construct F4 possessed the minimum tensile stress and the maximum tensile 
strain. This is attributed to a lack of patterned PCL foundation and therefore inter-
locking. Two breaking points are observed; PVP membrane fracture followed by the 
breakage of patterned PCL foundation. Mechanical properties of PCL construct 
components appear appreciably greater than PVP constituents, as the PCL breaking 
process was more prolonged compared to PVP. 
Stress-strain curves for constructs P1-P5, comprising various 3D print-patterned PCL 
filaments, are shown in Fig. 4(d). A similar two stage breaking process is observed 
irrespective of construct type. Construct P1 exhibits a maximum tensile stress of 0.3 
MPa with the greatest tensile strain of 147%. However, the tensile stress for construct 
P2 decreased to 0.26 MPa with a minimum tensile strain of 53.6%. This is due to 
differences in fiber stacking and repetition; since construct P2 possessed reduced 
intercalation (ten fibers were stacked in one axis for P2, whereas those in P1 were 
intercalated on a layer-by-layer basis). This indicates fiber printing and intercalating 
sequence through mutli-axial layering impacts the overall constructs mechanical 
properties. Construct P3 comprised parallelogram shaped voids (45°), which would 
enable greater flexibility. Thus, its maximum tensile stress was ~0.5 MPa with the 
17 
 
maximum tensile strain close to 500%. The greatest tensile stress for construct P4 was 
0.7 MPa, although it possessed a breaking tensile strain of ~362%, with the difference 
between P1 and P4 being inclusion of magnetic NPs (P4). The results coincide with a 
previous report citing well dispersed Fe3O4 NPs improve mechanical properties of 
fibrous systems[31]. Construct P5 displayed best mechanical properties; with a 
maximum tensile stress of >1.2 MP and the greatest tensile strain (~659%). For this 
construct, NPs were also incorporated in to the superficial PVP membrane. Therefore, 
construct design parameters such as printing sequence, direction, angle and additive 
inclusion provide routes to modulate mechanical properties of hybrid drug delivery 
systems. 
 
3.4 Construct hydrophilicity 
Biomaterial contact angle has significant impact on drug release from a device [16] and 
the materials surface is the first point of interaction with biological (host) surroundings. 
Thus, wettability is influenced primarily by surface characteristics which in turn 
impacts bio-interface behaviour [32, 33]. In addition, wettability has also been shown 
to modulate hydrophobicity, which is an important parameter in drug release from a 
delivery system [34]. Therefore, the constructs produced in this study incorporate both 
hydrophilic (PVP) and hydrophobic (PCL) fibers, making it a potential active carrier 
delivery system for controlled and sustained drug release. Device hydrophilicity was 
determined by measuring direct contact angles (CAs) between a PBS droplet (1uL, pH 
7.4) and the constructs surface. Initial CA and its gradual change at pre-determined time 
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intervals on constructs F1-F4 and P1-P5 were measured, as shown in Fig. 5. The initial 
PBS CA on construct surface are presented in Fig. 5(a) and 5(c), respectively. Fig. 5(b) 
and 5(d) are magnified digital images of droplet behaviour on EHD-hybrid engineered 
construct surfaces at 0, 100 and 300 s. The initial CA for F1 was 39°, which 
subsequently reduced to ~0° after 100s. This is due to the highly hydrophilic nature of 
PVP polymer, which dissolved spontaneously in PBS [35]. CAs of constructs F2, F3 
and F4 were near identical ~70° (at 0 sec). After 300s the CA of F3 was ~ 0°. The 
overcoat membrane for both constructs is most likely to be the driving factor for these 
values. Hoverer, constructs F2 and F4 show similar CAs over 0-100s. This is due to 
PCL stability and resistance to rapid PBS degradation. Previous findings report PCL 
fibers to exhibit deionized water CAs of ~110° [36], which suggests test medium, void  
space and porosity change could all impact CA behavior. 
Constructs P1-P5 possess fibrous PVP layering. However, differences in CA were 
observed which are attributed to the aligned PCL foundations. The CA of construct P1 
was 40°, which is near identical to construct F1. However, altering PCL foundation 
geometry to stacked, with parallelogram void structure or made to host Fe3O4 NPs 
within foundations reduces device hydrophilicity, which is identical to construct F2 
(PCL foundation loaded with TE-HCL and Fe3O4 NPs). CAs of constructs P1-P5 
decreased with time, due to dissolution of PVP membranes. According to the results, 
coupling EHD continuous jetting PCL foundations with PVP membranes enhances the 
CAs. Furthermore, as described earlier, the difference in sample contrast (shown in Fig. 
3(a1)-(e1)), which arises due to change in micro-structure height may also be 
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responsible for variations to CAs. However, all construct CAs were below 90°, 
indicating their hydrophilic nature with good wettability. Thus, constructs fulfilled 
moisture integration requirements that is crucial for active interaction at the bio-
interface. 
 
3.5 In vitro TE-HCL release studies 
TE-HCL release behaviours from constructs was investigated in PBS (pH 7.4, 
triplicate) at the ambient temperature (25℃). TE-HCL release from fundamental 
constructs F1- F4 were investigated with and without an external AMF, as shown in 
Fig. 6(a). It could be observed that with the aid of an AMF trigger, TE-HCL release 
was expedited. PVP membranes dissolved rapidly in PBS, causing TE-HCL release 
from construct F1 reaching 96% at 600 min with an AMF, with the non-triggered 
construct releasing over 75% of the antibiotic. However, TE-HCL release from 
construct F2 was retarded up to 60 min, and reached 20% at 600 min without AMF 
application. The slow and prolonged release of TE-HCL from construct F2 is due to the 
hydrophobic nature of PCL. TE-HCL release reached only 40% at 600 min for construct 
F2, but was enhanced upon application of AMF, which is far less when compared to 
other constructs. For TE-HCL release from co-polymer systems comprising aligned 
PCL foundations and a PVP membrane (F3 and F4), a rapid release of TE-HCL was 
followed by a long period of sustained release, indicating a two-tier mechanism. 
Comparing construct F3 to F4, the latter displayed a much lower and prolonged active 
release rate that was due to increased PCL quantities in the overall composition (PCL-
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PVP-PCL). The release behaviour of TE-HCL from constructs P1-P5 are shown in Fig. 
6(b). TE-HCL was only incorporated in PVP membranes for constructs P1-P5. 
Constructs P4 and P5 are identical to P1, except for Fe3O4 NPs incorporation into P4 
and P5. Due to the highly hydrophilic nature of PVP polymer, all TE-HCL release 
profiles were near complete at 30 min, and constructs P1-P3 exhibit rapid active release 
during the first 3 min followed by sustained release over the next 18 min. However, it 
was found that appreciable variations in TE-HCL release behaviour from patterned PCL 
platforms is clear. Modification of PCL foundation pattern on the PVP membrane 
accelerated TE-HCL release. At 3 minutes, the releases of TE-HCL from constructs P1-
P3 reached ~90%. This initial rapid release is attributed to TE-HCL drug distribution 
near or embedded in the surface of the PVP membrane of constructs. Over the 21 min’ 
assessment period, constructs P1-P3 all released 100% TE-HCL. However, release of 
TE-HCL from pure PVP fiber membrane was ~77.6%, indicating an impact on the 
initial burst release phase. Previous studies have shown that modification to a scaffold 
like structure (or a 3D matrix) is a viable approach to control drug release [37]. The 
rapid release of TE-HCL from PVP matrix clearly suggests potential applications where 
rapid action is required. TE-HCL release from constructs P4 and P5 also present a 
similar trend, although drug release was further investigated using AMF. Triggered 
drug release from constructs P4-P5 (both loaded with 0.5 % w/w Fe3O4 NPs and 0.5% 
TE-HCL) was assessed over a similar assessment release period. The introduction of 
AMF (~40 KHz) around NP embedded constructs induced greater drug release 
compared to the non-treated sample (P1). The release of TE-HCL from constructs P4 
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and P5 reached 100% within the first 2 min. This is due to intensified motion of 
molecules within NP embedded constructs (P4 and P5) with actuated activity of Fe3O4 
NPs upon exposure to AMF. Drug release profiles indicate AMF could be used to 
accelerate active release and geometry of PCL foundations has a clear influence on the 
rate of drug release.  
Drug release data for constructs F1-F4 were fitted to Korsmeyer-Peppas and Higuchi 
models. For Korsmeyer-Peppas model; regression coefficients and n values were 
calcuated (Table 2). For F1, F2, F3 and F4 constructs; n values were 0.0858, 0.4792, 
0.0735 and 0.0668, respectively. Here, for n < 0.45 Fickian diffusion is most likely, 
while for 0.45 < n < 0.89, an anomalous transport process is suggested, which involves 
various factors; demanding at least two parameters to clarify diffusion and relexation 
behavior for non-Fickian diffusion [16, 25, 38]. Based on n values the drug release 
mechanism from F2 (pure PCL fibers) appears to follow non-Fickian diffusion. As n < 
0.45 was estabilished for constructs F1, F3 and F4, Fickian diffusion dominates the 
drug release process. For Higuchi model, if the cumulative drug release content is 
linearly dependent on square root of time, drug release is likely to be diffusion-
controlled [39]. Drug release data with corresponding parameters is displayed in Table 
2. The high R2 values suggests that drug release from all complicated constructs is via 
diffusion mechanism. While both models are in agreement for release mechanisms 
related to constructs F1, F3 and F4; construct F2 could actually be classed to display 
Quasi-Fickian diffusion as demonstrated in previous studies since n is below 0.5 [40].   
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Fig. 6(c) shows an electron micrograph of construct F1 during the TE-HCL in vitro 
release study removed at 20s. PVP fibers had lost their integrity and appeared as shard 
structures. Fig. 6(d) shows an electron micrograph of construct F2 removed from the in 
vitro study at 600 min. PCL fibers also become less well-defined with irregular and 
swollen topographical features due to interaction and uptake of the release medium via 
diffusion. However, it could be seen that TE-HCL encapsulated in both PVP membrane 
and PCL patterned foundations (in a single device) could deliver a two-tier active 
release strategy. Furthermore, Fe3O4 NPs have the potential to enhance TE-HCL 
release. Thus, considering aforementioned release mechanisms, together with Fe3O4 NP 
induced effects, bespoke construct engineering using functional materials, geometrical 
features and polymer variations provide multi-modal therapy potential. 
 
3.6 Antimicrobial activity and biological evaluation of constructs 
Construct antimicrobial activity was investigated using E.coli as the test 
microorganism. Construsts were prepared using PCL patterned foundations loaded with 
TE-HCL. Constructs F2 and F3 were selected for assessment. Fig. 7(a-c) show disc 
samples to form inhibition zones at 16, 20 and 24 h incubation. The inhibition zones 
appear stable during this period. However, inhibition zone diameter for disc F3 was 
significantly wider than both F2 and the PCL foundation (loaded with TE-HCL only) 
as shown in Fig. 7(d). This could be due attributed to PVP membrane overcoat hosting 
TE-HCL and Fe3O4 NPs. Inhibition zones for disc F2 were lower than PCL foundations, 
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indicating Fe3O4 NPs could also reduce antimicrobial activity. The three construct discs 
display clear inhibition zones, indicating antimicrobial function.  
Although both PCL and PVP are FDA approved materials, multi-matieral constructs 
still pose potential toxic risks to cells due to residual solvent, process induced changes 
and environmental impact. Hence, a biological assay was performed to evaluate 
cytotoxicity of constructs F2 and F3. Due to PVP hydrophilicity, the polymer was 
blended with PCL and TE-HCL, and the system was used as the modified covering 
membrane for construct F3. The PCL foundation was identical to foundations devised 
for specimen F2. Cell behavior on construct F2 and F3 was observed using fluorescent 
microscopy over a four day cell culture period. Fig. 7(e1)-(f4) show micrographs 
obtained from fluorescent microscopy. HUVEC were stained red for F-actin and blue 
for cell nuclei. After incubation for four days, both consructs F2 (Fig. 7(e1)-(e4)) and 
F3 (Fig. 7(f1)-(f4)) showed biocompatibility. A large number of cells were on the 
samples, especially for patterned PCL foundations (Fig. 7(e1)-(e4)), HUVEC 
accumulated on aligned PCL filaments assuming the shape of grids as shown in 
micrographs. However, during the incubation period, cell proliferation and growth was 
observed for constructs F2 and F3. Cell mprhology appeared spindled, suggesting cell 
growth on both components. Therefore, these results confirm complex construct 





In summary, complex constructs comprising patterned PCL foundations and 
electrospun PVP membranes were successfully fabricated using a hybrid EHD 
apparatus; merging ES and EHD continuous jetting. Results show structure 
complexity through geometrical variation, material selection and co-engineering 
platform. The presence of various components was confirmed using FTIR. 
Alteration to the printed base PCL foundation influenced PBS contact angle, 
mechanical properties and TE-HCL release profiles. Classical burst release of 
TE-HCL was observed from constructs, which could be tailored through PCL 
foundation geometry. Furthermore, two-tier drug release was achieved based on 
PCL foundation (sustained) and PVP coating membrane (rapid). For the 
sustained release, AMF trigger provided a route to expedite antibiotic release. All 
constructs exhibited antibacterial activity and good cell biocompatibility. The 
findings indicate potential value for hybrid engineering and novel multi-stage 
therapies. 
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Table and Figure Captions 
Tables 
Table 1(a). Detailed descriptions of constructs F1-F4. 
Table 1(b). Detailed description of constructs P1-P5. The total number of layers for 
all construct foundations was 20. 
Table 2. Application of Korsmeyer-Peppas and Higuchi models to drug released 
from constructs F1-F4. 
 
Figures 
Fig. 1. Schematic diagram of hybrid EHD apparatus comprising both 3D-printing and 
electrospinning components. Example of engineered construct (and process) shown in 
two electron micrographs; firstly as the mechanically supporting aligned PCL fibrous 
platform and then randomly spun PVP membrane on its surface. 
Fig. 2. (a)-(d) are Optical micrographs of constructs F1-F4 (scale bar = 500 μm). (a1) - 
(d1) show electron micrographs of constructs F1-F4. Insets (a1)-(d1) are high 
magnifications of constructs F1-F4. 
Fig. 3. (a)-(e) are optical micrographs of constructs P1-P5 (scale bar = 500 μm). (a1) - 
(e1) show electron micrographs of constructs P1-P5 (scale bar = 500 μm). (a2) - (e2) 
are inclined electron micrographs of constructs P1-P5 (scale bar = 200 μm). 
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Fig. 4. (a) FTIR spectra of pure PCL, Fe3O4 NPs, TE-HCL and PVP. (b) FTIR spectra 
of constructs P1-P5. (c) Stress-strain curves for constructs F1-F4. (d) Stress-strain 
curves for constructs P1-P5. 
Fig. 5. (a) and (c) are contact angles for constructs F1-F4 and P1-P5 at 0 s, respectively, 
upon instant droplet-membrane contact (t < 1s). (b) and (d) show droplet spreading on 
constructs at selected time internals (1 <, 100 and 300 s). 
Fig. 6. (a) TE-HCL release profiles from constructs F1-4, with and without AMF 
application. (b) TE-HCL release profiles from constructs P1-5. Error bars indicate mean 
±standard deviation (sample number n=3). (c) Electron micrograph of construct F1 
removed at 20s during in vitro release study. (d) Electron micrograph of PCL construct 
P2 removed at 600 min during in vitro release study. 
Fig. 7. Inhibition zones for PCL constructs F2 and F3 (incubated with E. coli) at (a) 16 
(b) 20 and (c) 24h. (d) Inhibition zone diameter at various assessment time points. (e)-
(f) are fluorescent micrographs of HUVEC cultured on constructs F2 and F3 (at day 4) 
showing; (e1 and f1) bright-field micrographs, (e2 and f2) HUVEC cytoskeleton, (e3 

























Table 1(b)  





































Construct Model Equation n R2 
F1 Korsmeyer-
Pappas 
Log (Mt/M∞ × 100) = 1.7867 + 0.0858 × log (t) 0.0858 0.9797 
Higuchi Mt/M∞ × 100 = 59.6452 + 4.4864 × t 1/2 — 0.9574 
F2 Korsmeyer-
Pappas 
Log (Mt/M∞ × 100) = -0.0097 + 0.4792 × log (t) 0.4792 0.9530 
Higuchi Mt/M∞ × 100 = 1.4201 + 0.7876 × t 1/2 — 0.9536 
F3 Korsmeyer-
Pappas 
Log (Mt/M∞ × 100) = 1.5583 + 0.0735 × log (t) 0.0735 0.9566 
Higuchi Mt/M∞ × 100 = 45.6095 + 0.5167 × t 1/2 — 0.9528 
F4 Korsmeyer-
Pappas 
Log (Mt/M∞ × 100) = 1.4030 + 0.0668 × log (t) 0.0668 0.9872 
Higuchi Mt/M∞ × 100 = 31.9500 + 0.2753 × t 1/2 — 0.9563 
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